1. Clobazam‐treated patients with Lennox‐Gastaut syndrome experienced fewer seizure‐related injuries than placebo patients during trial OV‐1012. (4th May 2016) Authors: Isojarvi, Jouko; Lee, Deborah; Peng, Guangbin; Sperling, Michael R. Journal: Epilepsia Issue: Volume 57:issue 6(2016) Page Start: e113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Deconstructing tolerance with clobazam: Post hoc analyses from an open-label extension study. (25th October 2016) Authors: Gidal, Barry E.; Wechsler, Robert T.; Sankar, Raman; Montouris, Georgia D.; White, H. Steve; Cloyd, James C.; Kane, Mary Clare; Peng, Guangbin; Tworek, David M.; Shen, Vivienne; Isojarvi, Jouko Journal: Neurology Issue: Volume 87:Number 17(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Intravenous carbamazepine as short‐term replacement therapy for oral carbamazepine in adults with epilepsy: Pooled tolerability results from two open‐label trials. (25th April 2015) Authors: Lee, Deborah; Kalu, Uwa; Halford, Jonathan J.; Biton, Victor; Cloyd, James; Klein, Pavel; Bekersky, Ihor; Peng, Guangbin; Dheerendra, Suresh; Tolbert, Dwain Journal: Epilepsia Issue: Volume 56:issue 6(2015:Jun.) Page Start: 906 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗